Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +50.50%
#3 Velvet Velvet +35.70%
#4 Black Phoenix Black Phoenix +34.70%
#5 Akedo Akedo +14.19%
#6 DoubleZero DoubleZero +12.81%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.80%
#8 HOME HOME +11.06%
#9 Cross Cross +10.56%
#10 Pieverse Pieverse +9.40%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Hexima Limited Hexima Limited

Hexima Limited

HXL
Classement en actions #39776
Hexima Limited is a biotechnology firm focused on the discovery and advancement... Hexima Limited is a biotechnology firm focused on the discovery and advancement of plant-derived proteins and peptides for medical applications in humans. Its primary drug candidate, pezadeftide, a plant defensin, is presently undergoing Phase IIb clinical evaluations in Australia and New Zealand to address fungal toenail infections. The company was established in 1997 and its main operations are situated in Preston, Australia.
Prix de l'action
$0.0084929
Dernière synchronisation: 2024-11-12
Capitalisation boursière
$354.66K
Changement (1 jour)
-0.64%
Changement (1 an)
0.00%
Pays
AU
Échange Hexima Limited (HXL)

Catégorie

Healthcare
Ratio P/B pour Hexima Limited (HXL)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Hexima Limited, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Hexima Limited de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE